Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

NCT06488105 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Lipid Disorder
Hypercholesterolemia
Cardiovascular Diseases
Atherosclerosis

Interventions

DRUG: Statin (rosuvastatin 10 or 40 mg daily, depending on risk)
BEHAVIORAL: Healthy Lifestyle Counseling
OTHER: Outpatient Followup

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]
[object Object]